Optimizing endocrine therapy for breast cancer
- PMID: 15755964
- DOI: 10.1200/JCO.2005.01.005
Optimizing endocrine therapy for breast cancer
Comment on
-
Adjuvant endocrine therapy for premenopausal women with early breast cancer.J Clin Oncol. 2005 Mar 10;23(8):1736-50. doi: 10.1200/JCO.2005.11.050. J Clin Oncol. 2005. PMID: 15755982 Review. No abstract available.
-
Advances in adjuvant hormonal therapy for postmenopausal women.J Clin Oncol. 2005 Mar 10;23(8):1751-9. doi: 10.1200/JCO.2005.11.038. J Clin Oncol. 2005. PMID: 15755983 Review. No abstract available.
Similar articles
-
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.J Clin Oncol. 2007 Feb 10;25(5):486-92. doi: 10.1200/JCO.2006.08.8617. Epub 2007 Jan 2. J Clin Oncol. 2007. PMID: 17200148 Clinical Trial.
-
Adjuvant endocrine therapy in premenopausal women with breast cancer.Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14. Breast Cancer Res Treat. 2010. PMID: 20711666 No abstract available.
-
Adjuvant endocrine treatment of early breast cancer.Hematol Oncol Clin North Am. 2007 Apr;21(2):223-38. doi: 10.1016/j.hoc.2007.03.002. Hematol Oncol Clin North Am. 2007. PMID: 17512446 Review.
-
The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.Clin Adv Hematol Oncol. 2008 Aug;6(8):573-4. Clin Adv Hematol Oncol. 2008. PMID: 18820598 Review. No abstract available.
-
The role of aromatase inhibitor (AI) in the treatment of breast cancer.Acta Med Indones. 2005 Jan-Mar;37(1):43-8. Acta Med Indones. 2005. PMID: 15879638 Review. No abstract available.
Cited by
-
The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer.Int J Clin Pract. 2007 Dec;61(12):2051-63. doi: 10.1111/j.1742-1241.2007.01587.x. Epub 2007 Sep 24. Int J Clin Pract. 2007. PMID: 17892469 Free PMC article. Review.
-
Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials.Front Oncol. 2019 Jun 21;9:510. doi: 10.3389/fonc.2019.00510. eCollection 2019. Front Oncol. 2019. PMID: 31281796 Free PMC article. Review.
-
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer.Breast Cancer (Dove Med Press). 2022 Jul 14;14:163-173. doi: 10.2147/BCTT.S353332. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 35860287 Free PMC article. Review.
-
Breast Cancer Treatments: Updates and New Challenges.J Pers Med. 2021 Aug 19;11(8):808. doi: 10.3390/jpm11080808. J Pers Med. 2021. PMID: 34442452 Free PMC article. Review.
-
Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?Ger Med Sci. 2013;11:Doc05. doi: 10.3205/000173. Epub 2013 Feb 18. Ger Med Sci. 2013. PMID: 23423877 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical